{
    "nctId": "NCT02535221",
    "briefTitle": "Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER+ & HER2- Breast Cancer",
    "officialTitle": "Randomized Trial of Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With Estrogen Receptor-Positive HER2 Negative Breast Cancer",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 234,
    "primaryOutcomeMeasure": "ultrasound response rate",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* 35 years old \\<age\u226455 years old, in premenopausal status(with the judgement by researchers when the patients are recruited) Histologically confirmed primary invasive breast cancer\n* Stage: T2N0M0(cT\\>2cm, SLNB negative), hard to proceed the breast conserving surgery(not feasible or may affect the appearance of breast)\n* Histologically confirmed HR+ (ER or PR positive, and \\>50% cell in IHC) HER2 negative breast cancer by pathological evaluation\n* No other previous treatment for primary breast cancer\n* Without other tumor or unstable complication or uncontrolled infection\n* No contradiction for the third generation AIs, LHRHa, chemotherapy\n* Attend the study voluntarily, sign the informed consent.\n\nExclusion Criteria:\n\n* Metastasis disease by pathological or radiological diagnosis\n* the history of other tumor\n* contradiction for the third generation AIs, LHRHa, chemotherapy\n* Contradiction for adjuvant chemotherapy: serious cardiology or cerebral vessel disease, liver or kidney disfunction, blood system disease, the other situation or complication that are not suitable or cannot adaptable for chemotherapy\n* Contradiction for proceeding surgery: contradiction for anesthesia, large lesion,T4, lymph node positive\n* other situation not suitable for the research: psychological disease, mental disorder, social problem, geographic problem\n* have been attendance in other anti-tumor treatment or other clinical trials 8) reject to attend the study",
    "sex": "FEMALE",
    "minimumAge": "35 Years",
    "stdAges": "ADULT"
}